Enclomiphene Regulatory Status in India: DCGI Flags Unapproved Manufacture and Marketing
The Enclomiphene regulatory status in India has come under scrutiny after the…
Antacids and Kidney Injury: What You Should Know About PPI Safety
Acidity, heartburn and acid reflux are common problems, and medicines that reduce…
FDA Approves Tudriqev for Advanced Melanoma: Uses, Mechanism, Efficacy and Safety
The Tudriqev FDA approval marks an important development in cancer immunotherapy. Tudriqev…
Lupin Biosimilars: $100 Million Growth Plan, 505(b)(2) Pipeline and India Innovation Strategy
Lupin biosimilars are becoming an important part of Lupin Limited's global growth…
Chandipura Virus in Gujarat: Symptoms, Transmission & Prevention
Last Updated: August 2026 Disclaimer: This article is for public health awareness…
Drugs, Medical Devices and Cosmetics Bill 2026: Key Proposals and Impact on India’s Pharma Sector
The Drugs, Medical Devices and Cosmetics Bill 2026 could bring a major…
Scientists Identify Immune Cell Pathway That Could Help Prevent Severe Allergic Reactions
Researchers from Japan have discovered a previously unknown immune pathway that may…
Eisai Launches Leqembi in India: Alzheimer’s Drug Enters Indian Market at ₹21,682 Per Vial
The Eisai Launches Leqembi in India announcement marks a major milestone in…
Circular RNAs in Cancer Therapy: A Breakthrough for Reducing Treatment Side Effects
Cancer treatment has advanced significantly over the past decade, improving survival rates…
Dr. Reddy’s Rituximab Biosimilar Receives US FDA Approval, Strengthening Global Biologics Portfolio
Dr. Reddy's Laboratories has achieved another major milestone with the US FDA…
IPA Seeks to Regularise Legacy Drugs in India: What It Means for the Pharmaceutical Industry
The IPA Legacy Drugs Regularisation India initiative has emerged as an important…
Amgen Data Breach 2026: Patient Health Information Potentially Exposed in Cybersecurity Incident
Global biotechnology company Amgen has disclosed a significant cybersecurity incident that may…
AI in Pharma R&D: Advanced Digital Technologies Are Rewiring Drug Discovery and Development
The adoption of AI in Pharma R&D is accelerating as pharmaceutical companies…
AbbVie Q2 2026 Results: Skyrizi and Rinvoq Drive Double-Digit Revenue Growth Despite Humira Decline
The AbbVie Q2 2026 Results demonstrate the company's successful transition beyond its…
Sun Pharma Q1 FY27 Results: Revenue Grows 10.1%, India Business Up 16%
Sun Pharma Q1 FY27 Results reported a strong start to FY2027, with…
